Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2007-05-07

Clinical Trial Update: Galantamine Executive Function in Parkinson's Disease [NA]

View source ↗

Summary

This is a clinical trial update examining galantamine for executive function in Parkinson's disease. The current status of the trial is listed as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Galantamine (galantamine)

Snippet

Sponsor: Memorial Hospital of Rhode Island | Conditions: Parkinson's Disease | NA | Status: UNKNOWN